rabeprazole has been researched along with Esophageal Dysmotility in 5 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The improvement in dysmotility-like dyspepsia symptom score on day 28 was significantly greater in the rabeprazole group (22." | 5.16 | Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. ( Amemoto, K; Ashida, K; Esaki, H; Fukuchi, T; Hashimoto, T; Isowa, G; Kiyota, K; Majima, K; Morikawa, H; Murotani, M; Ohyama, Y; Oka, H; Sakaguchi, M; Takao, F; Takao, M; Yamashita, H, 2012) |
| "Patients with uninvestigated dyspepsia (n = 104; male/female 41/63) were treated with either rabeprazole 10 mg o." | 3.76 | Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia. ( Asaoka, D; Hojo, M; Ishikawa, D; Kawabe, M; Nagahara, A; Oguro, M; Osada, T; Otaka, M; Shimada, Y; Watanabe, S; Yoshizawa, T, 2010) |
| "Compared to erosive GERD, clear differences existed in pretreatment prevalence of symptoms and responsiveness to RPZ in grades N and M; the results suggested stomachaches (especially at night) were significant symptoms in grade N and dysmotility-like symptoms like bloated stomach were significant in grade M while gastroesophageal reflux symptoms were significant in erosive GERD." | 2.73 | It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients. ( Chiba, T; Hongo, M; Kinoshita, Y; Kusano, M; Shirai, N; Yamaguchi, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oridate, N | 1 |
| Takeda, H | 1 |
| Mesuda, Y | 1 |
| Nishizawa, N | 1 |
| Furuta, Y | 1 |
| Asaka, M | 1 |
| Fukuda, S | 1 |
| Nagahara, A | 1 |
| Asaoka, D | 1 |
| Hojo, M | 1 |
| Oguro, M | 1 |
| Shimada, Y | 1 |
| Ishikawa, D | 1 |
| Osada, T | 1 |
| Kawabe, M | 1 |
| Yoshizawa, T | 1 |
| Otaka, M | 1 |
| Watanabe, S | 1 |
| Sakaguchi, M | 1 |
| Takao, M | 1 |
| Ohyama, Y | 1 |
| Oka, H | 1 |
| Yamashita, H | 1 |
| Fukuchi, T | 1 |
| Ashida, K | 1 |
| Murotani, M | 2 |
| Majima, K | 1 |
| Morikawa, H | 1 |
| Hashimoto, T | 1 |
| Kiyota, K | 1 |
| Esaki, H | 1 |
| Amemoto, K | 1 |
| Isowa, G | 1 |
| Takao, F | 1 |
| Tsutsui, H | 1 |
| Manabe, N | 1 |
| Uno, M | 1 |
| Imamura, H | 1 |
| Kamada, T | 1 |
| Kusunoki, H | 1 |
| Shiotani, A | 1 |
| Hata, J | 1 |
| Harada, T | 1 |
| Haruma, K | 1 |
| Kusano, M | 1 |
| Shirai, N | 1 |
| Yamaguchi, K | 1 |
| Hongo, M | 1 |
| Chiba, T | 1 |
| Kinoshita, Y | 1 |
3 trials available for rabeprazole and Esophageal Dysmotility
| Article | Year |
|---|---|
Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzamides; Dyspepsia; Esop | 2012 |
Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Chi-Square Distribution; Drug Resistance; Elec | 2012 |
It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Endoscopy, Digestive System | 2008 |
2 other studies available for rabeprazole and Esophageal Dysmotility
| Article | Year |
|---|---|
Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngopharyngeal reflux symptoms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Enzyme Inhibitors; Esophage | 2008 |
Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Dyspepsia; Esophageal Motility Disorders | 2010 |